Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 2
2006 1
2007 2
2010 1
2012 1
2015 1
2016 1
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.
Biglia N, Mariani L, Sgro L, Mininanni P, Moggio G, Sismondi P. Biglia N, et al. Endocr Relat Cancer. 2007 Sep;14(3):549-67. doi: 10.1677/ERC-06-0060. Endocr Relat Cancer. 2007. PMID: 17914088 Review.
A growing body of evidence support the association between the use of hormone replacement therapy (HRT) and a higher risk of both invasive lobular carcinoma (ILC) and invasive ductal-lobular mixed carcinoma (IDLC). Overall biologic …
A growing body of evidence support the association between the use of hormone replacement therapy (HRT) and a higher risk of both inv …
Management of in situ lobular neoplasia detected on needle core biopsy of breast.
Purdie CA, McLean D, Stormonth E, Macaskill EJ, McCullough JB, Edwards SL, Brown DC, Jordan LB. Purdie CA, et al. J Clin Pathol. 2010 Nov;63(11):987-93. doi: 10.1136/jcp.2010.081687. J Clin Pathol. 2010. PMID: 20972243
AIMS: To evaluate the risk of having occult ductal carcinoma in situ or invasive carcinoma in the region of a focus of lobular (in situ) neoplasia (LN) diagnosed on needle core biopsy (NCB) of breast. ...Of the 50 patients, 13 (26%) had a final …
AIMS: To evaluate the risk of having occult ductal carcinoma in situ or invasive carcinoma in the region of a focus of …
Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands.
Louwman MW, Vriezen M, van Beek MW, Nolthenius-Puylaert MC, van der Sangen MJ, Roumen RM, Kiemeney LA, Coebergh JW. Louwman MW, et al. Int J Cancer. 2007 Jul 1;121(1):127-35. doi: 10.1002/ijc.22625. Int J Cancer. 2007. PMID: 17330844
The relatively small group of patients with breast tumors other than the ductal, lobular or mixed ducto-lobular types, has reached nonnegligible numbers due to the ongoing increase in the incidence of breast cancer. ...The proportion of s …
The relatively small group of patients with breast tumors other than the ductal, lobular or mixed ducto-lobul …
Detection Rates for Benign and Malignant Diagnoses on Breast Cancer Screening With Digital Breast Tomosynthesis in a Statewide Mammography Registry Study.
Fujii MH, Herschorn SD, Sowden M, Hotaling EL, Vacek PM, Weaver DL, Sprague BL. Fujii MH, et al. AJR Am J Roentgenol. 2019 Mar;212(3):706-711. doi: 10.2214/AJR.18.20255. Epub 2019 Jan 23. AJR Am J Roentgenol. 2019. PMID: 30673339 Free PMC article.
OBJECTIVE: The objective of our study was to determine whether detection rates of specific benign and malignant diagnoses differ for breast cancer screening with digital breast tomosynthesis (DBT) versus full-field digital mammography (FFDM) alone. ...Among benign d …
OBJECTIVE: The objective of our study was to determine whether detection rates of specific benign and malignant diagnoses differ for brea …
Distinct signatures of codon and codon pair usage in 32 primary tumor types in the novel database CancerCoCoPUTs for cancer-specific codon usage.
Meyer D, Kames J, Bar H, Komar AA, Alexaki A, Ibla J, Hunt RC, Santana-Quintero LV, Golikov A, DiCuccio M, Kimchi-Sarfaty C. Meyer D, et al. Genome Med. 2021 Jul 28;13(1):122. doi: 10.1186/s13073-021-00935-6. Genome Med. 2021. PMID: 34321100 Free PMC article.
For example, a substantial increase in GGT-glycine was observed in invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC), and mixed invasive ductal and lobular carcinoma (IDLC) of the breast. ...These find …
For example, a substantial increase in GGT-glycine was observed in invasive ductal carcinoma (IDC), invasive lobular …
Contrast-Enhanced Digital Mammography in the Surgical Management of Breast Cancer.
Ali-Mucheru M, Pockaj B, Patel B, Pizzitola V, Wasif N, Stucky CC, Gray R. Ali-Mucheru M, et al. Ann Surg Oncol. 2016 Dec;23(Suppl 5):649-655. doi: 10.1245/s10434-016-5567-7. Epub 2016 Sep 15. Ann Surg Oncol. 2016. PMID: 27638679
METHODS: A retrospective review of prospective breast surgery and breast imaging databases for patients who underwent CEDM and had breast cancer surgery. ...The mean age was 62 years (range 25-85 years). The histology was 65 % invasive ductal carcin …
METHODS: A retrospective review of prospective breast surgery and breast imaging databases for patients who underwent CEDM and …
Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Acs G, et al. Am J Clin Pathol. 2001 Jan;115(1):85-98. doi: 10.1309/FDHX-L92R-BATQ-2GE0. Am J Clin Pathol. 2001. PMID: 11190811
We studied the pattern of E-cadherin expression in 183 invasive carcinomas (100 ductal, 42 lobular, 41 with mixed ductal and lobular features) and 198 in situ carcinomas (131 ductal, 53 lobular, 14 in situ with ductal and …
We studied the pattern of E-cadherin expression in 183 invasive carcinomas (100 ductal, 42 lobular, 41 with mixed du …
Cost comparison of radiation treatment options after lumpectomy for breast cancer.
Greenup RA, Camp MS, Taghian AG, Buckley J, Coopey SB, Gadd M, Hughes K, Specht M, Smith BL. Greenup RA, et al. Ann Surg Oncol. 2012 Oct;19(10):3275-81. doi: 10.1245/s10434-012-2546-5. Epub 2012 Aug 1. Ann Surg Oncol. 2012. PMID: 22851048
BACKGROUND: Radiation therapy (RT) after lumpectomy for breast cancer can be delivered with several different regimens. ...RESULTS: Median patient age was 56.5 years (range 32-93 years). Tumor histology included invasive ductal cancer (78 %), ductal …
BACKGROUND: Radiation therapy (RT) after lumpectomy for breast cancer can be delivered with several different regimens. ...RES …
Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
Chung A, Gangi A, Amersi F, Bose S, Zhang X, Giuliano A. Chung A, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S422-7. doi: 10.1245/s10434-015-4829-0. Epub 2015 Aug 27. Ann Surg Oncol. 2015. PMID: 26310280
BACKGROUND: This study aimed to evaluate the impact that the release of consensus guidelines for margins in breast-conserving surgery (BCS) had on re-excision rates. METHODS: A retrospective review examined a prospectively maintained database of patients who had operable i …
BACKGROUND: This study aimed to evaluate the impact that the release of consensus guidelines for margins in breast-conserving surgery …
Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G, Fountzilas G, Bafaloukos D, Koutsoukou V, Pectasides D, Skarlos D, Samantas E, Kalofonos HP, Gogas H, Pavlidis N. Pentheroudakis G, et al. Breast Cancer Res Treat. 2006 Jun;97(3):237-44. doi: 10.1007/s10549-005-9117-4. Epub 2005 Dec 2. Breast Cancer Res Treat. 2006. PMID: 16322882
INTRODUCTION: Breast cancer patients developing liver metastases have traditionally been considered to make up a poor prognosis group with median survival rates of less than 6 months. ...RESULTS: Median age at diagnosis was 54.5 years, with the majority of women being fit …
INTRODUCTION: Breast cancer patients developing liver metastases have traditionally been considered to make up a poor prognosis group …
11 results